Home » TASK-2 Activators

TASK-2 Activators

Early Discovery

Lead Generation

Lead Optimisation

Preclinical Development

Modality

Small molecules

Therapeutic area

Neuroscience

Advantages

Despite important roles in pathophysiology, K2Ps have proven a difficult target class to modulate with small molecules. LifeArc has developed and successfully deployed a novel system to identify small molecule K2P activators, and have strategic relationships in place to deliver high quality drug discovery in the K2P space.

Background info

Two pore domain potassium channels (K2Ps) have been implicated in a number of human diseases including Pain and Migraine. A number of K2Ps show genetic linkage (e.g. Migraine for TASK2 and TRESK). LifeArc has active chemistry programs for TASK-2 with potent and efficacious activators identified.

Indication

Pain and Migraine

Contact us

Name(Required)

First Last

Organisation

Role

Email(Required)

Enter Email Confirm Email

Phone number

Comments(Required)

Please let us know what's on your mind. Have a question for us? Ask away.

Comments

This field is for validation purposes and should be left unchanged.

In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. If you would like your data to be removed, please email info@lifearc.org.

Please see our Privacy Policy in relation to the personal data you submit to us through this page.